Seizure remission and improvement of neurological function in sialidosis with perampanel therapy
Su-Ching Hu, Kun-Long Hung, Hui-Ju Chen and 1 more
Epilepsy and Behavior Case Reports · 2018
doi:10.1016/j.ebcr.2018.02.005 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
A 15-year-old boy experienced myoclonic seizures for 3 years. He initially had occasional myoclonus, gradually progressive ataxia, tremors, and psychomotor and speech regression developed. Eventually, he exhibited nearly continuous myoclonus. He received treatment of sodium valproate, levetiracetam, clobazam, and phenobarbital, without efficacy. A ketogenic diet also proved ineffective. Adjunctive therapy with 4 mg/day of perampanel was started and was gradually titrated to 10 mg/day. The remission of myoclonic seizures was achieved within one month. The patient's neurological and cognitive functions improved to a certain degree during the following 20 months. Sialidosis was confirmed by the mutations of NEU1 gene. Keywords: Progressive myoclonic epilepsy, Sialidosis, Perampanel, NEU1 gene
Abstract licence: CC BY-NC
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.